FDA Drug Shortages

Current and Resolved Drug Shortages and Discontinuations Reported to FDA

Start Over | Back to Previous Screen

Dacarbazine for Injection, USP
Status: Discontinuation
»Therapeutic Categories: Oncology

Hospira, Inc. (New 01/14/2021)

Company Contact Information:

Presentation Posting Date Related Information
200 mg Single Dose ONCO-TAIN™ Glass Fliptop Vial (NDC 61703-0327-22) 01/14/2021 Discontinuation of the manufacture of the drug

Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English